AC-262536

CAS No. 870888-46-3

AC-262536( AC 262536 | AC262536 )

Catalog No. M27843 CAS No. 870888-46-3

AC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 Get Quote
5MG 58 Get Quote
10MG 102 Get Quote
25MG 222 Get Quote
50MG 380 Get Quote
100MG 565 Get Quote
500MG 1215 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AC-262536
  • Note
    Research use only, not for human use.
  • Brief Description
    AC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor.
  • Description
    AC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor. It has partial agonist activity with respect to testosterone and suppresses luteinizing hormone.(In Vitro):AC-262536 inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP in a dose-dependent manner. The effects are significant with 100 nM, and reaches a plateau with 1 μM.(In Vivo):In male sprague-dawley rats, administration of AC-262536 (subcutaneous injection, once daily for 14 consecutive days) significantly decreased LH levels by about 40% at the 3 mg/kg dose. At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
  • In Vitro
    AC-262536 dose-dependently inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP. The effects are significant with 100 nM AC-262536 (%inhibition 47.2±12.2), and reaches a plateau with 1 μM treatment (%inhibition 50.7±7.6). Thus, AC-262536 can act as a functional antagonist in prostate cells.
  • In Vivo
    AC-262536 (3, 10, 30 mg/kg) reverses the luteinizing hormone (LH) spike in castrated rats. Animal Model:Male Sprague-Dawley rats (200-225 g)Dosage:3, 10 and 30 mg/kg Administration:Administered subcutaneously; once daily for 14 consecutive days Result:Significantly decreased LH levels by about 40% at the 3 mg/kg dose.The ED50 was determined to be 2.8 mg/kg.At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
  • Synonyms
    AC 262536 | AC262536
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    870888-46-3
  • Formula Weight
    278.355
  • Molecular Formula
    C18H18N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (179.63 mM)
  • SMILES
    OC1C[C@@H]2CC[C@H](C1)N2c1ccc(C#N)c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.El-Sayed, May A.; Al-Gendy, Amal. A.; Hamdan, Dalia. I.; El-Shazly, Assem M. Phytoconstituents, LC-?ESI-?MS profile, antioxidant and antimicrobial activities of Citrus x limon L. Burm. f. Cultivar variegated pink lemon. Journal of Pharmaceutical Sciences and Research (2017), 9(4), 375-391.
molnova catalog
related products
  • Nandrolone phenpropi...

    Nandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.

  • 2-hydroxy Flutamide

    2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR)?for the treatment of prostate cancer.

  • Flutamide

    Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.